However, special consideration is given to candidates from the following fields which would complement the expertise of our current team of principal investigators: mRNA and LNP technology, B-cell biology, antibody engineering, structural biology, mucosal immunology, innate immunity and adjuvant design, animal- and human-derived 3D tissue modelling, stem cell biology (animal-/human-derived tissues), micro-physiological systems (MPS), organ-on-chip, zoonotic diseases, drug/vaccine testing and validation for zoonotic diseases, machine learning in infectious disease research and epidemiology and modelling. The expectations for group leaders are to establish their laboratories and their own line of innovative research within this period of time, apply and win independent funding, publish
mehr